Renaissance Technologies
ONCY

Renaissance Technologies’s Oncolytics Biotech ONCY Stock Holding History

Renaissance Technologies’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$608K Buy
+715,838
New +$712K ﹤0.01% 2518
2023
Q2 		– Sell
-129,856
Closed -$156K – 4174
2023
Q1 		$156K Buy
129,856
+17,256
+15% +$27.1K ﹤0.01% 3360
2022
Q4 		$184K Buy
112,600
+88,000
+358% +$134K ﹤0.01% 3447
2022
Q3 		$30K Buy
24,600
+10,600
+76% +$13K ﹤0.01% 3846
2022
Q2 		$14K Sell
14,000
-11,500
-45% -$14K ﹤0.01% 4147
2022
Q1 		$40K Sell
25,500
-209,978
-89% -$352K ﹤0.01% 3936
2021
Q4 		$327K Buy
235,478
+25,578
+12% +$47.3K ﹤0.01% 3301
2021
Q3 		$439K Buy
209,900
+186,900
+813% +$423K ﹤0.01% 2936
2021
Q2 		$64K Buy
+23,000
New +$70.4K ﹤0.01% 3383
2021
Q1 		– Sell
-174,220
Closed -$415K – 3595
2020
Q4 		$415K Buy
174,220
+161,635
+1,284% +$387K ﹤0.01% 2902
2020
Q3 		$21K Buy
+12,585
New +$23.1K ﹤0.01% 3322
2020
Q2 		– Sell
-41,999
Closed -$58K – 3675
2020
Q1 		$58K Buy
+41,999
New +$105K ﹤0.01% 3303
2019
Q4 		– Sell
-37,751
Closed -$22K – 3676
2019
Q3 		$22K Buy
+37,751
New +$38.4K ﹤0.01% 3374
2018
Q4 		– Sell
-15,800
Closed -$61K – 3535
2018
Q3 		$61K Buy
+15,800
New +$73.4K ﹤0.01% 3270

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies's ONCY Position: Q1 2026 in Review

Renaissance Technologies opened a new position in Oncolytics Biotech (ONCY) in Q1 2026: 715,838 shares worth $608K. The stake represents ﹤0.01% of the portfolio and ranks #2518 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in ONCY as recently as Q1 2023.

Renaissance Technologies first reported a position in ONCY in Q3 2018 and has held it in 14 quarters since. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • Renaissance Technologies held 715,838 shares of Oncolytics Biotech worth $608K as of Q1 2026.
  • Oncolytics Biotech was a new Renaissance Technologies position in Q1 2026.
  • Oncolytics Biotech made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2518 holding.
  • Renaissance Technologies first reported a position in Oncolytics Biotech in Q3 2018 and has held it in 14 quarters since.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.